New PET scan could reveal how your immune system fights cancer
NCT ID NCT05259709
First seen Oct 31, 2025 · Last updated May 08, 2026 · Updated 35 times
Summary
This study tests a new imaging agent (89Zr-DFO-REGN5054) that may show where immune cells are active in tumors. About 50 adults with advanced solid cancers will receive the agent and a PET scan, along with the immunotherapy cemiplimab. The goal is to check safety and see if the scan can help predict treatment response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UMC Groningen
RECRUITINGGroningen, 9700 RB, Netherlands
Conditions
Explore the condition pages connected to this study.